Co-Authors
This is a "connection" page, showing publications co-authored by FASIHA KANWAL and GEORGE CHOLANKERIL.
Connection Strength
6.505
-
Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea". J Hepatol. 2024 May; 80(5):e218-e219.
Score: 0.971
-
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
Score: 0.893
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
Score: 0.825
-
NAFLD and HCC: Time to Bridge the Gap. Hepatology. 2021 11; 74(5):2336-2338.
Score: 0.821
-
Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 Mar 01; 119(3):497-504.
Score: 0.238
-
Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
Score: 0.230
-
Posttransplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transpl. 2023 07 01; 29(7):777-780.
Score: 0.228
-
Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
Score: 0.227
-
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4.
Score: 0.224
-
Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070.
Score: 0.217
-
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma. Transplant Direct. 2022 May; 8(5):e1313.
Score: 0.214
-
Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
Score: 0.213
-
Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver Transpl. 2022 01; 28(1):123-126.
Score: 0.209
-
Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
Score: 0.206
-
Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int. 2021 Oct; 34(10):1971-1983.
Score: 0.206
-
Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation. 2020 11; 104(11):2221-2224.
Score: 0.194
-
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
Score: 0.058
-
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
Score: 0.058
-
Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology. 2023 07 01; 78(1):179-194.
Score: 0.056
-
Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692.
Score: 0.056
-
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1.
Score: 0.055
-
Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
Score: 0.053
-
Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544.
Score: 0.052